Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the interest coverage ratio high or low?
The interest coverage ratio of -15.10x is 96% above its 4-year average of -378.00x, near the high end of its 4-year range (-1798.33x–-15.10x).
As of the fiscal period ended Wednesday, June 30, 2021.
Reported quarterly interest coverage; no daily interpolation. Q2 FY2021 (2021-06-30): -15.10x.
INTEREST COVERAGE RATIO
-15.10x
INTEREST COVERAGE RATIO AVG TTM
N/A
INTEREST COVERAGE RATIO AVG 3Y
-111.56x
INTEREST COVERAGE RATIO AVG 5Y
-378.00x
INTEREST COVERAGE RATIO AVG 10Y
N/A
INTEREST COVERAGE RATIO AVG 15Y
N/A
INTEREST COVERAGE RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
+86.46%
CURRENT VS 5Y AVG
+96.00%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-5.64x
median of 468 covered companies
CURRENT VS SECTOR MEDIAN
-167.57%
vs the sector median at left
Indaptus Therapeutics, Inc.
Market Cap
$285.37M
Interest Coverage Ratio
-15.10x
TTM Avg
N/A
3Y Avg
-111.56x
5Y Avg
-378.00x
Market Cap
$287.55M
Interest Coverage Ratio
-23.92x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$282.68M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$288.15M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$288.27M
Interest Coverage Ratio
-3588.65x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$288.34M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$279.05M
Interest Coverage Ratio
-25.79x
TTM Avg
0.59x
3Y Avg
0.59x
5Y Avg
0.59x
Market Cap
$277.96M
Interest Coverage Ratio
-203.41x
TTM Avg
43.82x
3Y Avg
43.82x
5Y Avg
43.82x
Market Cap
$275.66M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | INTEREST COVERAGE RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Indaptus Therapeutics, Inc. (INDP) | $285.37M | -15.10x | N/A | -111.56x | -378.00x |
| Abeona Therapeutics Inc. (ABEO)vs › | $287.55M | -23.92x | N/A | N/A | N/A |
| Fulcrum Therapeutics, Inc. (FULC)vs › | $282.68M | N/A | N/A | N/A | N/A |
| Sagimet Biosciences Inc. (SGMT)vs › | $288.15M | N/A | N/A | N/A | N/A |
| Standard BioTools Inc. (LAB)vs › | $288.27M | -3588.65x | N/A | N/A | N/A |
| BridgeBio Oncology Therapeutics Inc. (BBOT)vs › | $288.34M | N/A | N/A | N/A | N/A |
| Aurora Cannabis Inc. (ACB)vs › | $279.05M | -25.79x | 0.59x | 0.59x | 0.59x |
| SAB Biotherapeutics, Inc. (SABS)vs › | $277.96M | -203.41x | 43.82x | 43.82x | 43.82x |
| Fate Therapeutics, Inc. (FATE)vs › | $275.66M | N/A | N/A | N/A | N/A |
| Larimar Therapeutics, Inc. (LRMR)vs › | $295.61M | N/A | 40.84x | 40.84x | 40.84x |
Interest Coverage
-15.1x
Debt/Equity
0.00
Current Ratio
19.48
Formula: Interest Coverage = EBIT / Interest Expense
Reference ranges:
Note: Interest coverage should be compared with historical interest expense, operating income, and industry capital structure.
Interest Coverage = EBIT / Interest Expense
The interest coverage ratio measures operating earnings relative to interest expense.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | INTEREST COVERAGE RATIO |
|---|---|
| 2021-06-30 | -15.10x |
| 2019-12-31 | -400.56x |
| 2018-12-31 | -27.22x |
| 2018-09-30 | -91.39x |
| 2018-06-30 | -23.54x |
| 2018-03-31 | -1798.33x |
| 2017-03-30 | -289.88x |
| 2015-09-30 | -671.31x |
| 2015-03-30 | 179.32x |
